234 research outputs found

    Overview of studies evaluated for neuropsychiatric adverse events.

    Full text link
    <p>MSF: Médecins sans Frontières; SMRU: Shoklo Malaria Research Unit. These studies have been published: [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0168780#pone.0168780.ref013" target="_blank">13</a>,<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0168780#pone.0168780.ref014" target="_blank">14</a>,<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0168780#pone.0168780.ref034" target="_blank">34</a>–<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0168780#pone.0168780.ref048" target="_blank">48</a>].</p

    Two-way sensitivity analysis results showing the impact of changes in the level of adherence to primaquine regimens.

    Full text link
    <p>Green represents disability-adjusted life-years (DALYs) averted by the screening strategy for a cohort of 1000 individuals. For costs, yellow indicates increased costs and blue indicates cost savings for the screening strategy for one individual. For net monetary benefit (<i>NMB</i>), purple indicates scenarios where the screening strategy would be cost-effective at a threshold of US$500 (<i>T</i>) where <i>NMB = T × ΔDALYs– ΔCosts</i>.</p
    • …
    corecore